A Meta analysis of risk factors for pulmonary hypertension related to bronchopulmonary dysplasia in preterm infants

Zhen-Zhu YAO, Ai-Zhen YU, Xue FENG

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (3) : 293-300.

PDF(827 KB)
HTML
PDF(827 KB)
HTML
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (3) : 293-300. DOI: 10.7499/j.issn.1008-8830.2503011
CLINICAL RESEARCH

A Meta analysis of risk factors for pulmonary hypertension related to bronchopulmonary dysplasia in preterm infants

Author information +
History +

Abstract

Objective To systematically evaluate the incidence and risk factors of pulmonary hypertension (PH) associated with bronchopulmonary dysplasia (BPD) in preterm infants. Methods Cohort and case-control studies on the incidence and risk factors of PH complicating BPD (hereinafter referred to as BPD-PH) in preterm infants, published from database inception to July 2024, were retrieved from China National Knowledge Infrastructure, Wanfang Data, VIP Database, Chinese Biomedical Literature Database, PubMed, Web of Science, Embase, MEDLINE, and Cochrane Library. Meta analysis was performed using Stata 15.0 software. Results A total of 15 studies involving 4 561 preterm infants were included. Meta analysis results showed that the overall incidence of BPD-PH in preterm infants was 20.1% (95%CI: 16.1%-24.0%). Hemodynamically significant patent ductus arteriosus (OR=3.43), mechanical ventilation duration (OR=1.05), small for gestational age (SGA) (OR=7.30), severe BPD (OR=13.25), patent ductus arteriosus requiring surgical ligation (OR=6.03), oligohydramnios (OR=7.24), ventilator-associated pneumonia (OR=3.97), and respiratory distress syndrome (OR=2.70) were identified as risk factors for BPD-PH in preterm infants (P<0.05). Conclusions The overall incidence of BPD-PH in preterm infants is relatively high. Hemodynamically significant patent ductus arteriosus, mechanical ventilation duration, SGA, severe BPD, patent ductus arteriosus requiring surgical ligation, oligohydramnios, ventilator-associated pneumonia, and respiratory distress syndrome can increase the risk of PH in preterm infants with BPD, and clinical monitoring should prioritize BPD infants with these high-risk factors.

Key words

Bronchopulmonary dysplasia / Pulmonary hypertension / Risk factor / Meta analysis / Preterm infant

Cite this article

Download Citations
Zhen-Zhu YAO , Ai-Zhen YU , Xue FENG. A Meta analysis of risk factors for pulmonary hypertension related to bronchopulmonary dysplasia in preterm infants[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(3): 293-300 https://doi.org/10.7499/j.issn.1008-8830.2503011

References

[1]
Choi EK, Shin SH, Kim EK, et al. Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18-24 months of corrected age[J]. BMC Pediatr, 2019, 19(1): 26. PMCID: PMC6337852. DOI: 10.1186/s12887-019-1400-3 .
[2]
Arjaans S, Zwart EAH, Ploegstra MJ, et al. Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: a systematic review and meta-analysis[J]. Paediatr Perinat Epidemiol, 2018, 32(3): 258-267. DOI: 10.1111/ppe.12444 .
[3]
Hocq C, Vanhoutte L, Guilloteau A, et al. Early diagnosis and targeted approaches to pulmonary vascular disease in bronchopulmonary dysplasia[J]. Pediatr Res, 2022, 91(4): 804-815. DOI: 10.1038/s41390-021-01413-w .
[4]
Chan S, Brugha R, Quyam S, et al. Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia: a guide for paediatric respiratory specialists[J]. BREATHE, 2023, 18(4): 220209. PMCID: PMC9973460. DOI: 10.1183/20734735.0209-2022 .
[5]
Häfner F, Johansson C, Schwarzkopf L, et al. Current diagnosis and treatment practice for pulmonary hypertension in bronchopulmonary dysplasia: a survey study in Germany (PUsH BPD)[J]. Pulm Circ, 2023, 13(4): e12320. PMCID: PMC10739109. DOI: 10.1002/pul2.12320 .
[6]
Keller RL. Pulmonary hypertension and pulmonary vasodilators[J]. Clin Perinatol, 2016, 43(1): 187-202. DOI: 10.1016/j.clp.2015.11.013 .
[7]
Chen Y, Zhang D, Li Y, et al. Risk factors and outcomes of pulmonary hypertension in infants with bronchopulmonary dysplasia: a meta analysis[J]. Front Pediatr, 2021, 9: 695610. PMCID: PMC8267150. DOI: 10.3389/fped.2021.695610 .
[8]
齐利峰, 麦玉真, 姚芳, 等. 支气管肺发育不良合并肺动脉高压危险因素的Logistic回归分析[J]. 南京医科大学学报(自然科学版), 2015, 35(7): 1022-1025. DOI: 10.7655/NYDXBNS20150723 .
[9]
王陈红, 施丽萍, 马晓路, 等. 早产儿支气管肺发育不良伴肺动脉高压的临床特征及预后[J]. 中国当代儿科杂志, 2018, 20(11): 893-896. PMCID: PMC7389022. DOI: 10.7499/j.issn.1008-8830.2018.11.003 .
[10]
陈春, 黄鹏, 林冰纯, 等. 早产儿支气管肺发育不良伴肺动脉高压的高危因素与转归[J]. 中华儿科杂志, 2020, 58(9): 747-752. DOI: 10.3760/cma.j.cn112140-20200327-00310 .
[11]
孙俊芳, 蔡成, 翁博雯, 等. 极早产儿支气管肺发育不良相关性肺动脉高压的临床研究[J]. 中华新生儿科杂志, 2020, 35(6): 401-405. DOI: 10.3760/cma.j.issn.2096-2932.2020.06.001 .
[12]
王丽容. 早产儿支气管肺发育不良相关性肺动脉高压的临床特征及影响因素[J]. 吉林医学, 2022, 43(2): 392-394. DOI: 10.3969/j.issn.1004-0412.2022.02.039 .
[13]
岳伟红, 余加林. 早产儿支气管肺发育不良并发肺动脉高压的危险因素分析[J]. 儿科药学杂志, 2022, 28(2): 42-46. DOI: 10.13407/j.cnki.jpp.1672-108X.2022.02.013 .
[14]
Wang C, Ma X, Xu Y, et al. A prediction model of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia[J]. Front Pediatr, 2022, 10: 925312. PMCID: PMC9354604. DOI: 10.3389/fped.2022.925312 .
[15]
戴淑珍, 李书书, 周美云, 等. 支气管肺发育不良伴肺动脉高压的危险因素评估与列线图预测模型构建[J]. 中华儿科杂志, 2023, 61(10): 902-909. DOI: 10.3760/cma.j.cn112140-20230616-00406 .
[16]
范浩钦, 王丹, 庄严, 等. 极早产儿支气管肺发育不良相关肺动脉高压危险因素及预后分析[J]. 中华新生儿科杂志(中英文), 2023, 38(6): 338-343. DOI: 10.3760/cma.j.issn.2096-2932.2023.06.004 .
[17]
Branescu I, Shetty S, Richards J, et al. Pulmonary hypertension in preterm infants with moderate-to-severe bronchopulmonary dysplasia (BPD)[J]. Acta Paediatr, 2023, 112(9): 1877-1883. DOI: 10.1111/apa.16863 .
[18]
Chang HP, Lien R, Chu SM, et al. Outcomes of and factors associated with the development of bronchopulmonary dysplasia with pulmonary hypertension in very low birth weight infants: a retrospective study in a medical center[J]. Front Pediatr, 2023, 11: 1055439. PMCID: PMC10067740. DOI: 10.3389/fped.2023.1055439 .
[19]
Gentle SJ, Travers CP, Clark M, et al. Patent ductus arteriosus and development of bronchopulmonary dysplasia-associated pulmonary hypertension[J]. Am J Respir Crit Care Med, 2023, 207(7): 921-928. PMCID: PMC10111998. DOI: 10.1164/rccm.202203-0570OC .
[20]
曹婧可, 范浩钦, 肖云彬, 等. 极早产儿支气管肺发育不良相关肺动脉高压临床预测模型的建立和效能检验[J]. 中华儿科杂志, 2024, 62(2): 129-137. DOI: 10.3760/cma.j.cn112140-20230912-00178 .
[21]
刘选成, 谷名晓, 单若冰, 等. 极低出生体重儿支气管肺发育不良并发肺动脉高压的影响因素[J]. 山东医药, 2024, 64(4): 77-80. DOI: 10.3969/j.issn.1002-266X.2024.04.018 .
[22]
Wang D, Huang S, Cao J, et al. A comprehensive study on machine learning models combining with oversampling for bronchopulmonary dysplasia-associated pulmonary hypertension in very preterm infants[J]. Respir Res, 2024, 25(1): 199. PMCID: PMC11077703. DOI: 10.1186/s12931-024-02797-z .
[23]
Al-Ghanem G, Shah P, Thomas S, et al. Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis[J]. J PERINATOL, 2017, 37(4): 414-419. DOI: 10.1038/jp.2016.250 .
[24]
Abman SH, Hansmann G, Archer SL, et al. Pediatric pulmonary hypertension: guidelines from the American Heart Association and American Thoracic Society[J]. Circulation, 2015, 132(21): 2037-2099. DOI: 10.1161/CIR.0000000000000329 .
[25]
Krishnan U, Feinstein JA, Adatia I, et al. Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia[J]. J Pediatr, 2017, 188: 24-34.e1. DOI: 10.1016/j.jpeds.2017.05.029 .
[26]
Hansmann G, Koestenberger M, Alastalo TP, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT[J]. J Heart Lung Transplant, 2019, 38(9): 879-901. DOI: 10.1016/j.healun.2019.06.022 .
[27]
Yung D, Jackson EO, Blumenfeld A, et al. A multidisciplinary approach to severe bronchopulmonary dysplasia is associated with resolution of pulmonary hypertension[J]. Front Pediatr, 2023, 11: 1077422. PMCID: PMC10098720. DOI: 10.3389/fped.2023.1077422 .
[28]
Check J, Gotteiner N, Liu X, et al. Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia[J]. J PERINATOL, 2013, 33(7): 553-557. PMCID: PMC3633609. DOI: 10.1038/jp.2012.164 .
[29]
Wong PM, Lees AN, Louw J, et al. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia[J]. Eur Respir J, 2008, 32(2): 321-328. DOI: 10.1183/09031936.00127107 .
[30]
夏红萍, 张拥军. 重度支气管肺发育不良的表型特征和治疗策略[J]. 临床儿科杂志, 2022, 40(6): 401-406. DOI: 10.12372/jcp.2022.22e0605 .
[31]
Bancalari E, Claure N, Gonzalez A. Patent ductus arteriosus and respiratory outcome in premature infants[J]. Biol Neonate, 2005, 88(3): 192-201. DOI: 10.1159/000087582 .
[32]
Clyman R, Cassady G, Kirklin JK, et al. The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial[J]. J Pediatr, 2009, 154(6): 873-876. PMCID: PMC2709418. DOI: 10.1016/j.jpeds.2009.01.005 .
[33]
Kim HH, Sung SI, Yang MS, et al. Early pulmonary hypertension is a risk factor for bronchopulmonary dysplasia-associated late pulmonary hypertension in extremely preterm infants[J]. Sci Rep, 2021, 11(1): 11206. PMCID: PMC8160152. DOI: 10.1038/s41598-021-90769-4 .
[34]
Abman SH, Ivy DD, Archer SL, et al. Executive summary of the American Heart Association and American Thoracic Society joint guidelines for pediatric pulmonary hypertension[J]. Am J Respir Crit Care Med, 2016, 194(7): 898-906. PMCID: PMC5074658. DOI: 10.1164/rccm.201606-1183ST .
[35]
Varghese NP, Altit G, Gubichuk MM, et al. Navigating diagnostic and treatment challenges of pulmonary hypertension in infants with bronchopulmonary dysplasia[J]. J Clin Med, 2024, 13(12): 3417. PMCID: PMC11204350. DOI: 10.3390/jcm13123417 .

Footnotes

所有作者声明无利益冲突。

PDF(827 KB)
HTML

Accesses

Citation

Detail

Sections
Recommended

/